166 related articles for article (PubMed ID: 28409548)
1. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
Yang Y; Quan L; Ling Y
Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
[TBL] [Abstract][Full Text] [Related]
2. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Homeobox B5 (HOXB5) Inhibits Cell Proliferation, Migration, and Invasion in Non-Small Cell Lung Cancer Cells Through Inactivation of the Wnt/β-Catenin Pathway.
Zhang B; Li N; Zhang H
Oncol Res; 2018 Jan; 26(1):37-44. PubMed ID: 28337958
[TBL] [Abstract][Full Text] [Related]
4. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
[TBL] [Abstract][Full Text] [Related]
5. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
[TBL] [Abstract][Full Text] [Related]
6. RBMS3 delays disc degeneration by inhibiting Wnt/β-catenin signaling pathway.
Wang JJ; Liu XY; Du W; Liu JQ; Sun B; Zheng YP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):499-507. PubMed ID: 32016951
[TBL] [Abstract][Full Text] [Related]
7. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis.
Chen J; Kwong DL; Zhu CL; Chen LL; Dong SS; Zhang LY; Tian J; Qi CB; Cao TT; Wong AM; Kong KL; Li Y; Liu M; Fu L; Guan XY
PLoS One; 2012; 7(9):e44636. PubMed ID: 22957092
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
Fan Y; Guo Y
Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
[TBL] [Abstract][Full Text] [Related]
9. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
10. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway.
Hu Z; Xie L
Mol Med Rep; 2015 Sep; 12(3):4634-4639. PubMed ID: 26129710
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
Yang F; Xiao Z; Zhang S
Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
[TBL] [Abstract][Full Text] [Related]
13. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma.
Li Y; Chen L; Nie CJ; Zeng TT; Liu H; Mao X; Qin Y; Zhu YH; Fu L; Guan XY
Cancer Res; 2011 Oct; 71(19):6106-15. PubMed ID: 21844183
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.
Zhong J; Wang H; Yu J; Zhang J; Wang H
Oncol Res; 2017 Jul; 25(6):959-965. PubMed ID: 27938507
[TBL] [Abstract][Full Text] [Related]
16. Expression of RBMS3 in Breast Cancer Progression.
Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
[TBL] [Abstract][Full Text] [Related]
17. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
[TBL] [Abstract][Full Text] [Related]
18. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Vaishnavi A; Juan J; Jacob M; Stehn C; Gardner EE; Scherzer MT; Schuman S; Van Veen JE; Murphy B; Hackett CS; Dupuy AJ; Chmura SA; van der Weyden L; Newberg JY; Liu A; Mann K; Rust AG; Weiss WA; Kinsey CG; Adams DJ; Grossmann A; Mann MB; McMahon M
Cancer Res; 2022 Nov; 82(22):4261-4273. PubMed ID: 36112789
[TBL] [Abstract][Full Text] [Related]
19. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Liu H; Shi H; Fan Q; Sun X
Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
[TBL] [Abstract][Full Text] [Related]
20. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
